155 related articles for article (PubMed ID: 8837336)
1. Radioiodine therapy and Graves' ophthalmopathy.
Bartalena L; Marcocci C
Thyroid; 1996 Jun; 6(3):253. PubMed ID: 8837336
[No Abstract] [Full Text] [Related]
2. Does radioiodine cause the ophthalmopathy of Graves' disease?
McDougall IR
Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
[No Abstract] [Full Text] [Related]
3. Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.
Barth A; Probst P; Bürgi H
J Endocrinol Invest; 1991 Mar; 14(3):209-12. PubMed ID: 2071823
[TBL] [Abstract][Full Text] [Related]
4. Development of Graves' ophthalmopathy and uveitis after radioiodine therapy for Graves' disease in a patient with HTLV-I associated myelopathy (HAM).
Ozawa Y; Migita M; Watanabe T; Okuda I; Takeshita A; Takagi A; Shishiba Y
Intern Med; 1994 Sep; 33(9):564-8. PubMed ID: 8000111
[TBL] [Abstract][Full Text] [Related]
5. (131)I and thyroid-associated ophthalmopathy.
Rasmussen AK; Nygaard B; Feldt-Rasmussen U
Eur J Endocrinol; 2000 Aug; 143(2):155-60. PubMed ID: 10913933
[TBL] [Abstract][Full Text] [Related]
6. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole.
Kung AW; Yau CC; Cheng A
J Clin Endocrinol Metab; 1994 Aug; 79(2):542-6. PubMed ID: 7913934
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine and the immune system.
DeGroot LJ
Thyroid; 1997 Apr; 7(2):259-64. PubMed ID: 9133697
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine treatment, ablation, and ophthalmopathy: a balanced perspective.
Tallstedt L; Lundell G
Thyroid; 1997 Apr; 7(2):241-5. PubMed ID: 9133694
[TBL] [Abstract][Full Text] [Related]
9. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but...
Pinchera A; Bartalena L; Marcocci C
J Clin Endocrinol Metab; 1995 Feb; 80(2):342-5. PubMed ID: 7852486
[No Abstract] [Full Text] [Related]
11. Endocrine ophthalmopathy and radioiodine therapy.
Karlsson FA
Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
Gorman CA
J Clin Endocrinol Metab; 1995 Feb; 80(2):340-2. PubMed ID: 7852485
[No Abstract] [Full Text] [Related]
13. Graves' ophthalmopathy and 131I therapy.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine and aggravation of Graves' ophthalmopathy.
Vestergaard H; Laurberg P
Lancet; 1989 Jul; 2(8653):47. PubMed ID: 2567820
[No Abstract] [Full Text] [Related]
15. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
[TBL] [Abstract][Full Text] [Related]
16. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
[TBL] [Abstract][Full Text] [Related]
17. Airway complication occurring during radioiodine treatment for Graves' disease.
Kinuya S; Yoneyama T; Michigishi T
Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
[TBL] [Abstract][Full Text] [Related]
18. Post-radioiodine De Novo Onset Graves' Ophthalmopathy: Case Reports and a Review of the Literature.
Batra R; Krishnasamy SK; Buch H; Sandramouli S
Semin Ophthalmol; 2015 May; 30(3):227-31. PubMed ID: 24409943
[TBL] [Abstract][Full Text] [Related]
19. Graves' disease induced by Na(131)I therapy for toxic multinodular goitre.
van Leussen JJ; Edelbroek MA; Talsma MA; de Heide LJ
Neth J Med; 2000 Nov; 57(5):194-7. PubMed ID: 11185482
[TBL] [Abstract][Full Text] [Related]
20. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
